Consultation Document on the Transposition of Commision Directive (EU) 2017/1572 regarding the principles and guidelines of good manufacturing practice for medicinal products for human use
For more information please click here
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions